Intranasal Ketamine for Suicidal Ideation in Veterans

Phase 0 Withdrawn Bronx Veterans Medical Research Foundation, Inc Icahn School of Medicine at Mount Sinai · collab

NaSingle-groupOpen-labelTreatment

Summary

The objective of the current study is to investigate the safety, efficacy, and feasibility of multiple doses of intranasal (IN) ketamine for suicidal ideation Veterans.

Timeline

Start: 2020-01-01
Primary completion: 2020-01-31
Completion: 2020-04-30

Outcome

Outcome not reported

Stopped (Enrollment): “Study was never funded nor started, no participants were enrolled”

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ketamine	Small molecule	40 mg	Intranasal

Indications

No indication recorded.